Impact of Class III Obesity (Morbid Obesity) on the Perioperative, Functional, and Oncological Outcomes of Robotic-Assisted Radical Prostatectomy
Cancers · 19.02.2025 · 17 (4) · 709
DOI: 10.3390/cancers17040709 ↗Kurz gefasst
Fachartikel in der Zeitschrift Cancers, online erschienen am 19.02.2025. Verfasst von Abdel Rahman Jaber und 7 weiteren Autor:innen. Beteiligte Einrichtung: Adventhealth Global Robotics Institute, Celebration, FL 34747, USA. Die Arbeit wurde bisher 11-mal zitiert (Crossref) und nennt 34 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0).
Abstract (Originalsprache)
Background
The growing prevalence of obesity, particularly morbid obesity (BMI > 40 kg/m2), presents unique challenges in surgical management. In robotic-assisted radical prostatectomy (RARP) for prostate cancer, morbid obesity is associated with longer operative times, increased blood loss, and complex nerve-sparing procedures. These challenges may impact functional and oncological outcomes, making it essential to understand how high BMI affects RARP results. However, data on outcomes for patients with morbid obesity remain limited.
Methods
We retrospectively reviewed 14,444 patients who underwent RARP by a single surgeon from 2008 to 2023. A total of 183 patients with morbid obesity (BMI > 40 kg/m2) were matched 1:1 with 183 normal-weight patients (BMI 18.5–24.9 kg/m2) using propensity-score matching based on age, PSA levels, clinical staging, ISUP grade, comorbidities, and baseline urinary and sexual function scores. We compared perioperative variables, complications, and oncological and functional outcomes between groups.
Results
Patients with morbid obesity had longer console times (median 90 vs. 75 min, p < 0.001) and higher rates of estimated blood loss over 100 mL (39% vs. 22%, p = 0.001). Full nerve-sparing was less frequent in this group (16.9% vs. 38.8%, p < 0.001), and postoperative lymphocele formation rates were higher (12.7% vs. 6.0%, p = 0.021). While patients with morbid obesity demonstrated a higher incidence of pT3a disease (34.4% vs. 20.2%, p = 0.015), no significant differences were observed in BCR and PSM (24% vs. 18%, p = 0.25) or functional outcomes, such as potency and urinary continence, at 12 and 24 months after operation.
Conclusions
RARP in patients with morbid obesity is safe and feasible, with low rates of complications and no observed differences in functional and oncological outcomes compared to normal-weight patients. Further studies are needed to assess long-term outcomes in this growing patient population.
Schlagwörter
Stichwörter der Autor:innen
Autor:innen und Institutionen
- Adventhealth Global Robotics Institute, Celebration, FL 34747, USA.
- Urology Department, University of Central Florida (UCF), Orlando, FL 32816, USA.
- Big and Open Data Innovation Laboratory (BODaI-Lab) and Data Methods and Systems Statistical, 25122 Brescia, Italy.
ORCID-Profile: Shady Saikali, Marco Sandri
Zitieren
APA
Jaber, A. R., Saikali, S., Moschovas, M. C., Gamal, A., Patel, E., Sandri, M., Rogers, T., & Patel, V. (2025). Impact of Class III Obesity (Morbid Obesity) on the Perioperative, Functional, and Oncological Outcomes of Robotic-Assisted Radical Prostatectomy. Cancers, 17(4), 709. https://doi.org/10.3390/cancers17040709
Vancouver
Jaber AR, Saikali S, Moschovas MC, Gamal A, Patel E, Sandri M, et al. Impact of Class III Obesity (Morbid Obesity) on the Perioperative, Functional, and Oncological Outcomes of Robotic-Assisted Radical Prostatectomy. Cancers. 2025;17(4):709. doi:10.3390/cancers17040709
BibTeX
@article{Jaber2025,
author = {Jaber, Abdel Rahman and Saikali, Shady and Moschovas, Marcio Covas and Gamal, Ahmed and Patel, Ela and Sandri, Marco and Rogers, Travis and Patel, Vipul},
title = {Impact of Class III Obesity (Morbid Obesity) on the Perioperative, Functional, and Oncological Outcomes of Robotic-Assisted Radical Prostatectomy},
journal = {Cancers},
year = {2025},
volume = {17},
number = {4},
pages = {709},
doi = {10.3390/cancers17040709}
}
EUVIMED